{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T01:55:30Z","timestamp":1793498130236,"version":"4.5.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2020,2,15]],"date-time":"2020-02-15T00:00:00Z","timestamp":1581724800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,2,15]],"date-time":"2020-02-15T00:00:00Z","timestamp":1581724800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000071","name":"National Institute of Child Health and Human Development","doi-asserted-by":"publisher","award":["Z1AHD008735"],"award-info":[{"award-number":["Z1AHD008735"]}],"id":[{"id":"10.13039\/100000071","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Cancer Res Clin Oncol"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1007\/s00432-020-03138-5","type":"journal-article","created":{"date-parts":[[2020,2,15]],"date-time":"2020-02-15T11:03:12Z","timestamp":1581764592000},"page":"1051-1063","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":48,"title":["Clinical characteristics and outcomes of SDHB-related pheochromocytoma and paraganglioma in children and adolescents"],"prefix":"10.1007","volume":"146","author":[{"given":"Ivana","family":"Jochmanova","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"April Melody T.","family":"Abcede","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruby Jane S.","family":"Guerrero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chandy Lou P.","family":"Malong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Wesley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thanh","family":"Huynh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa K.","family":"Gonzales","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine I.","family":"Wolf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abhishek","family":"Jha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marianne","family":"Knue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamara","family":"Prodanov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naris","family":"Nilubol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leilani B.","family":"Mercado-Asis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Constantine A.","family":"Stratakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3541-3767","authenticated-orcid":false,"given":"Karel","family":"Pacak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,2,15]]},"reference":[{"key":"3138_CR1","doi-asserted-by":"publisher","first-page":"8812","DOI":"10.1200\/JCO.2005.03.1484","volume":"23","author":"L Amar","year":"2005","unstructured":"Amar L, Bertherat J, Baudin E et al (2005) Genetic testing in pheochromocytoma or functional paraganglioma. J Clin Oncol 23:8812\u20138818. https:\/\/doi.org\/10.1200\/JCO.2005.03.1484","journal-title":"J Clin Oncol"},{"key":"3138_CR2","doi-asserted-by":"publisher","first-page":"3822","DOI":"10.1210\/jc.2007-0709","volume":"92","author":"L Amar","year":"2007","unstructured":"Amar L, Baudin E, Burnichon N et al (2007) Succinate dehydrogenase B gene mutations predict survival in patients with malignant pheochromocytomas or paragangliomas. J Clin Endocrinol Metab 92:3822\u20133828. https:\/\/doi.org\/10.1210\/jc.2007-0709","journal-title":"J Clin Endocrinol Metab"},{"key":"3138_CR3","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1136\/adc.2008.139121","volume":"93","author":"R Armstrong","year":"2008","unstructured":"Armstrong R, Sridhar M, Greenhalgh KL et al (2008) Phaeochromocytoma in children. Arch Dis Child 93:899\u2013904. https:\/\/doi.org\/10.1136\/adc.2008.139121","journal-title":"Arch Dis Child"},{"key":"3138_CR4","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.surg.2016.05.050","volume":"161","author":"Y Assadipour","year":"2017","unstructured":"Assadipour Y, Sadowski SM, Alimchandani M et al (2017) SDHB mutation status and tumor size but not tumor grade are important predictors of clinical outcome in pheochromocytoma and abdominal paraganglioma. Surgery 161:230\u2013239. https:\/\/doi.org\/10.1016\/j.surg.2016.05.050","journal-title":"Surgery"},{"key":"3138_CR5","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/j.surg.2016.05.059","volume":"161","author":"B Babic","year":"2017","unstructured":"Babic B, Patel D, Aufforth R et al (2017) Pediatric patients with pheochromocytoma and paraganglioma should have routine preoperative genetic testing for common susceptibility genes in addition to imaging to detect extra-adrenal and metastatic tumors. Surgery 161:220\u2013227. https:\/\/doi.org\/10.1016\/j.surg.2016.05.059","journal-title":"Surgery"},{"key":"3138_CR6","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1196\/annals.1353.003","volume":"1073","author":"M Barontini","year":"2006","unstructured":"Barontini M, Levin G, Sanso G (2006) Characteristics of pheochromocytoma in a 4- to 20-year-old population. Ann NY Acad Sci 1073:30\u201337. https:\/\/doi.org\/10.1196\/annals.1353.003","journal-title":"Ann NY Acad Sci"},{"key":"3138_CR7","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1530\/ERC-13-0415","volume":"21","author":"B Bausch","year":"2014","unstructured":"Bausch B, Wellner U, Bausch D et al (2014) Long-term prognosis of patients with pediatric pheochromocytoma. Endocr Relat Cancer 21:17\u201325. https:\/\/doi.org\/10.1530\/ERC-13-0415","journal-title":"Endocr Relat Cancer"},{"key":"3138_CR8","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1136\/jmg.39.3.178","volume":"39","author":"BE Baysal","year":"2002","unstructured":"Baysal BE, Willett-Brozick JE, Lawrence EC et al (2002) Prevalence of SDHB, SDHC, and SDHD germline mutations in clinic patients with head and neck paragangliomas. J Med Genet 39:178\u2013183. https:\/\/doi.org\/10.1136\/jmg.39.3.178","journal-title":"J Med Genet"},{"key":"3138_CR9","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1007\/s00268-004-7134-9","volume":"28","author":"DG Beltsevich","year":"2004","unstructured":"Beltsevich DG, Kuznetsov NS, Kazaryan AM, Lysenko MA (2004) Pheochromocytoma surgery: epidemiologic peculiarities in children. World J Surg 28:592\u2013596. https:\/\/doi.org\/10.1007\/s00268-004-7134-9","journal-title":"World J Surg"},{"key":"3138_CR10","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1210\/jc.2005-1862","volume":"91","author":"DE Benn","year":"2006","unstructured":"Benn DE, Gimenez-Roqueplo AP, Reilly JR et al (2006) Clinical presentation and penetrance of pheochromocytoma\/paraganglioma syndromes. J Clin Endocrinol Metab 91:827\u2013836. https:\/\/doi.org\/10.1210\/jc.2005-1862","journal-title":"J Clin Endocrinol Metab"},{"key":"3138_CR11","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1016\/j.jpedsurg.2007.10.038","volume":"43","author":"NK Bissada","year":"2008","unstructured":"Bissada NK, Safwat AS, Seyam RM et al (2008) Pheochromocytoma in children and adolescents: a clinical spectrum. J Pediatr Surg 43:540\u2013543. https:\/\/doi.org\/10.1016\/j.jpedsurg.2007.10.038","journal-title":"J Pediatr Surg"},{"key":"3138_CR12","doi-asserted-by":"publisher","first-page":"4505","DOI":"10.1210\/jc.2006-0423","volume":"91","author":"FM Brouwers","year":"2006","unstructured":"Brouwers FM, Eisenhofer G, Tao JJ, Kant JA, Adams KT, Linehan WM, Pacak K (2006) High frequency of SDHB germline mutations in patients with malignant catecholamine-producing paragangliomas: implications for genetic testing. J Clin Endocrinol Metab 91:4505\u20134509. https:\/\/doi.org\/10.1210\/jc.2006-0423","journal-title":"J Clin Endocrinol Metab"},{"key":"3138_CR13","doi-asserted-by":"publisher","first-page":"L1","DOI":"10.1530\/ERC-12-0339","volume":"20","author":"A Cascon","year":"2013","unstructured":"Cascon A, Inglada-P\u00e9rez L, Comino-M\u00e9ndez I et al (2013) Genetics of pheochromocytoma and paraganglioma in Spanish pediatric patients. Endocr Relat Cancer 20:L1\u20136. https:\/\/doi.org\/10.1530\/ERC-12-0339","journal-title":"Endocr Relat Cancer"},{"key":"3138_CR14","doi-asserted-by":"publisher","first-page":"502734","DOI":"10.1155\/2014\/502734","volume":"2014","author":"H Choat","year":"2014","unstructured":"Choat H, Derrevere K, Knight L, Brown W, Mack EH (2014) SDHB-associated paraganglioma in a pediatric patient and literature review on hereditary pheochromocytoma-paraganglioma syndromes. Case Rep Endocrinol 2014:502734. https:\/\/doi.org\/10.1155\/2014\/502734","journal-title":"Case Rep Endocrinol"},{"key":"3138_CR15","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1053\/jpsu.2001.21612","volume":"36","author":"AO Ciftci","year":"2001","unstructured":"Ciftci AO, Tanyel FC, Senocak ME, Buyukpamukcu N (2001) Pheochromocytoma in children. J Pediatr Surg 36:447\u2013452. https:\/\/doi.org\/10.1053\/jpsu.2001.21612","journal-title":"J Pediatr Surg"},{"key":"3138_CR16","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1038\/ng.861","volume":"43","author":"I Comino-Mendez","year":"2011","unstructured":"Comino-Mendez I, Gracia-Azn\u00e1rez FJ, Schiavi F et al (2011) Exome sequencing identifies MAX mutations as a cause of hereditary pheochromocytoma. Nat Genet 43:663\u2013667. https:\/\/doi.org\/10.1038\/ng.861","journal-title":"Nat Genet"},{"key":"3138_CR17","doi-asserted-by":"publisher","DOI":"10.1530\/ERC-19-0024","author":"J Crona","year":"2019","unstructured":"Crona J, Lamarca A, Ghosal S, Welin S, Skogseid B, Pacak K (2019) Genotype-phenotype correlations in pheochromocytoma and paraganglioma. Endocr Relat Cancer. https:\/\/doi.org\/10.1530\/ERC-19-0024","journal-title":"Endocr Relat Cancer"},{"key":"3138_CR18","doi-asserted-by":"publisher","first-page":"2207","DOI":"10.1210\/jc.2012-1402","volume":"97","author":"R Darr","year":"2012","unstructured":"Darr R, Z\u00f6phel K, Eisenhofer G et al (2012) Combined use of 68Ga-DOTATATE and 18F-FDG PET\/CT to localize a bronchial carcinoid associated with ectopic ACTH syndrome. J Clin Endocrinol Metab 97:2207\u20132208. https:\/\/doi.org\/10.1210\/jc.2012-1402","journal-title":"J Clin Endocrinol Metab"},{"key":"3138_CR19","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1196\/annals.1353.017","volume":"1073","author":"RR De Krijger","year":"2006","unstructured":"De Krijger RR, Van Nederveen FH, Korpershoek E, De Herder WW, De Muinck Keizer-Schrama SM, Dinjens WN (2006) Frequent genetic changes in childhood pheochromocytomas. Ann NY Acad Sci 1073:166\u2013176. https:\/\/doi.org\/10.1196\/annals.1353.017","journal-title":"Ann NY Acad Sci"},{"key":"3138_CR20","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1016\/0022-3468(90)90219-y","volume":"25","author":"SH Ein","year":"1990","unstructured":"Ein SH, Shandling B, Wesson D, Filler R (1990) Recurrent pheochromocytomas in children. J Pediatr Surg 25:1063\u20131065. https:\/\/doi.org\/10.1016\/0022-3468(90)90219-y","journal-title":"J Pediatr Surg"},{"key":"3138_CR21","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.ccell.2017.01.001","volume":"31","author":"L Fishbein","year":"2017","unstructured":"Fishbein L, Leshchiner I, Walter V et al (2017) Comprehensive molecular characterization of pheochromocytoma and paraganglioma. Cancer Cell 31:181\u2013193. https:\/\/doi.org\/10.1016\/j.ccell.2017.01.001","journal-title":"Cancer Cell"},{"key":"3138_CR22","first-page":"5615","volume":"63","author":"AP Gimenez-Roqueplo","year":"2003","unstructured":"Gimenez-Roqueplo AP, Favier J, Rustin P et al (2003) Mutations in the SDHB gene are associated with extra-adrenal and\/or malignant phaeochromocytomas. Cancer Res 63:5615\u20135621","journal-title":"Cancer Res"},{"issue":"5","key":"3138_CR23","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1055\/s-0031-1301302","volume":"44","author":"AP Gimenez-Roqueplo","year":"2012","unstructured":"Gimenez-Roqueplo AP, Dahia PL, Robledo M (2012) An update on the genetics of paraganglioma, pheochromocytoma, and associated hereditary syndromes. Horm Metab Res 44(5):328\u2013333. https:\/\/doi.org\/10.1055\/s-0031-1301302","journal-title":"Horm Metab Res"},{"key":"3138_CR24","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1007\/s10689-010-9402-1","volume":"10","author":"EF Hensen","year":"2011","unstructured":"Hensen EF, Bayley JP (2011) Recent advances in the genetics of SDH-related paraganglioma and pheochromocytoma. Fam Cancer 10:355\u2013363. https:\/\/doi.org\/10.1007\/s10689-010-9402-1","journal-title":"Fam Cancer"},{"key":"3138_CR25","doi-asserted-by":"publisher","first-page":"2367","DOI":"10.1210\/jc.2018-01968","volume":"104","author":"S Hescot","year":"2019","unstructured":"Hescot S, Curras-Freixes M, Deutschbein T et al (2019) Prognosis of malignant pheochromocytoma and paraganglioma (MAPP-Prono Study): a European network for the study of adrenal tumors retrospective study. J Clin Endocrinol Metab 104:2367\u20132374. https:\/\/doi.org\/10.1210\/jc.2018-01968","journal-title":"J Clin Endocrinol Metab"},{"key":"3138_CR26","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1007\/s00259-017-3896-9","volume":"45","author":"A Jha","year":"2018","unstructured":"Jha A, Ling A, Millo C et al (2018) Superiority of (68)Ga-DOTATATE over (18)F-FDG and anatomic imaging in the detection of succinate dehydrogenase mutation (SDHx )-related pheochromocytoma and paraganglioma in the pediatric population. Eur J Nucl Med Mol Imaging 45:787\u2013797. https:\/\/doi.org\/10.1007\/s00259-017-3896-9","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"3138_CR27","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.1007\/s00432-017-2397-3","volume":"143","author":"I Jochmanova","year":"2017","unstructured":"Jochmanova I, Wolf KI, King KS et al (2017) SDHB-related pheochromocytoma and paraganglioma penetrance and genotype-phenotype correlations. J Cancer Res Clin Oncol 143:1421\u20131435. https:\/\/doi.org\/10.1007\/s00432-017-2397-3","journal-title":"J Cancer Res Clin Oncol"},{"key":"3138_CR28","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1016\/s0022-3468(83)80040-2","volume":"18","author":"BH Kaufman","year":"1983","unstructured":"Kaufman BH, Telander RL, van Heerden JA, Zimmerman D, Sheps SG, Dawson B (1983) Pheochromocytoma in the pediatric age group: current status. J Pediatr Surg 18:879\u2013884. https:\/\/doi.org\/10.1016\/s0022-3468(83)80040-2","journal-title":"J Pediatr Surg"},{"key":"3138_CR29","doi-asserted-by":"publisher","first-page":"4137","DOI":"10.1200\/JCO.2011.34.6353","volume":"29","author":"KS King","year":"2011","unstructured":"King KS, Prodanov T, Kantorovich V et al (2011) Metastatic pheochromocytoma\/paraganglioma related to primary tumor development in childhood or adolescence: significant link to SDHB mutations. J Clin Oncol 29:4137\u20134142. https:\/\/doi.org\/10.1200\/JCO.2011.34.6353","journal-title":"J Clin Oncol"},{"key":"3138_CR30","doi-asserted-by":"publisher","first-page":"3278","DOI":"10.1210\/jc.2017-00816","volume":"102","author":"G Kong","year":"2017","unstructured":"Kong G, Grozinsky-Glasberg S, Hofman MS et al (2017) Efficacy of peptide receptor radionuclide therapy for functional metastatic paraganglioma and pheochromocytoma. J Clin Endocrinol Metab 102:3278\u20133287. https:\/\/doi.org\/10.1210\/jc.2017-00816","journal-title":"J Clin Endocrinol Metab"},{"key":"3138_CR31","volume-title":"WHO classification of tumours of endocrine organs WHO\/IARC classification of Tumours","year":"2017","unstructured":"Lloyd RV, Osamura RY, Kl\u00f6ppel G, Rosai J (eds) (2017) WHO classification of tumours of endocrine organs WHO\/IARC classification of Tumours, 4th edn. International Agency for Research on Cancer, Lyon","edition":"4"},{"issue":"2347\u20132354","key":"3138_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/hmg\/11.20.2347","volume":"11","author":"ER Maher","year":"2002","unstructured":"Maher ER, Eng C (2002) The pressure rises: update on the genetics of phaeochromocytoma. Hum Mol Genet 11(2347\u20132354):1. https:\/\/doi.org\/10.1093\/hmg\/11.20.2347","journal-title":"Hum Mol Genet"},{"key":"3138_CR33","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1055\/a-0851-3275","volume":"51","author":"L Mei","year":"2019","unstructured":"Mei L, Khurana A, Al-Juhaishi T, Faber A, Celi F, Smith S, Boikos S (2019) Prognostic factors of malignant pheochromocytoma and paraganglioma: a combined SEER and TCGA databases review. Horm Metab Res 51:451\u2013457. https:\/\/doi.org\/10.1055\/a-0851-3275","journal-title":"Horm Metab Res"},{"key":"3138_CR34","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1056\/NEJMoa020152","volume":"346","author":"HP Neumann","year":"2002","unstructured":"Neumann HP, Bausch B, McWhinney SR et al (2002) Germ-line mutations in nonsyndromic pheochromocytoma. N Engl J Med 346:1459\u20131466. https:\/\/doi.org\/10.1056\/NEJMoa020152","journal-title":"N Engl J Med"},{"key":"3138_CR35","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1001\/jama.292.8.943","volume":"292","author":"HP Neumann","year":"2004","unstructured":"Neumann HP, Pawlu C, Peczkowska M (2004) Distinct clinical features of paraganglioma syndromes associated with SDHB and SDHD gene mutations. JAMA 292:943\u2013951. https:\/\/doi.org\/10.1001\/jama.292.8.943","journal-title":"JAMA"},{"key":"3138_CR36","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1530\/EJE-17-0074","volume":"177","author":"ND Niemeijer","year":"2017","unstructured":"Niemeijer ND, Rijken JA, Eijkelenkamp K et al (2017) The phenotype of SDHB germline mutation carriers: a nationwide study. Eur J Endocrinol 177:115\u2013125. https:\/\/doi.org\/10.1530\/EJE-17-0074","journal-title":"Eur J Endocrinol"},{"key":"3138_CR37","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1111\/cen.12191","volume":"79","author":"C Pamporaki","year":"2013","unstructured":"Pamporaki C, D\u00e4rr R, Bursztyn M et al (2013) Plasma-free vs deconjugated metanephrines for diagnosis of phaeochromocytoma. Clin Endocrinol (Oxf) 79:476\u2013483. https:\/\/doi.org\/10.1111\/cen.12191","journal-title":"Clin Endocrinol (Oxf)"},{"key":"3138_CR38","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1542\/peds.2005-2299","volume":"118","author":"TH Pham","year":"2006","unstructured":"Pham TH, Moir C, Thompson GB et al (2006) Pheochromocytoma and paraganglioma in children: a review of medical and surgical management at a tertiary care center. Pediatrics 118:1109\u20131117. https:\/\/doi.org\/10.1542\/peds.2005-2299","journal-title":"Pediatrics"},{"key":"3138_CR39","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1111\/cge.12591","volume":"89","author":"JA Rijken","year":"2016","unstructured":"Rijken JA, Niemeijer ND, Corssmit EP, Jonker MA, Leemans CR, Menko FH, Hensen EF (2016) Low penetrance of paraganglioma and pheochromocytoma in an extended kindred with a germline SDHB exon 3 deletion. Clin Genet 89:128\u2013132. https:\/\/doi.org\/10.1111\/cge.12591","journal-title":"Clin Genet"},{"key":"3138_CR40","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/s0094-0143(05)70088-4","volume":"27","author":"JH Ross","year":"2000","unstructured":"Ross JH (2000) Pheochromocytoma. Special considerations in children. Urol Clin N Am 27:393\u2013402. https:\/\/doi.org\/10.1016\/s0094-0143(05)70088-4","journal-title":"Urol Clin N Am"},{"key":"3138_CR41","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1186\/1471-2407-14-523","volume":"14","author":"J Schovanek","year":"2014","unstructured":"Schovanek J, Martucci V, Wesley R et al (2014) The size of the primary tumor and age at initial diagnosis are independent predictors of the metastatic behavior and survival of patients with SDHB-related pheochromocytoma and paraganglioma: a retrospective cohort study. BMC Cancer 14:523. https:\/\/doi.org\/10.1186\/1471-2407-14-523","journal-title":"BMC Cancer"},{"key":"3138_CR42","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1111\/j.1399-0004.2009.01157.x","volume":"75","author":"DC Solis","year":"2009","unstructured":"Solis DC, Burnichon N, Timmers HJ et al (2009) Penetrance and clinical consequences of a gross SDHB deletion in a large family. Clin Genet 75:354\u2013363. https:\/\/doi.org\/10.1111\/j.1399-0004.2009.01157.x","journal-title":"Clin Genet"},{"key":"3138_CR43","volume-title":"Paediatric endocrine tumours. A multi-disciplinary consensus statement of best practice from a working group convened under the auspices of the BSPED and UKCCSG (rare tumour working groups)","year":"2005","unstructured":"Spoudeas HA (ed) (2005) Paediatric endocrine tumours. A multi-disciplinary consensus statement of best practice from a working group convened under the auspices of the BSPED and UKCCSG (rare tumour working groups). Novo Nordisk Ltd, West Sussex"},{"key":"3138_CR44","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1016\/s0022-3476(63)80345-5","volume":"63","author":"RH Stackpole","year":"1963","unstructured":"Stackpole RH, Melicow MM, Uson AC (1963) Pheochromocytoma in children Report of 9 case and review of the first 100 published cases with follow-up studies. J Pediatr 63:314\u2013330. https:\/\/doi.org\/10.1016\/s0022-3476(63)80345-5","journal-title":"J Pediatr"},{"key":"3138_CR45","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1210\/jc.2006-2315","volume":"92","author":"HJ Timmers","year":"2007","unstructured":"Timmers HJ, Kozupa A, Eisenhofer G et al (2007) Clinical presentations, biochemical phenotypes, and genotype-phenotype correlations in patients with succinate dehydrogenase subunit B-associated pheochromocytomas and paragangliomas. J Clin Endocrinol Metab 92:779\u2013786. https:\/\/doi.org\/10.1210\/jc.2006-2315","journal-title":"J Clin Endocrinol Metab"},{"key":"3138_CR46","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1677\/ERC-08-0284","volume":"16","author":"HJ Timmers","year":"2009","unstructured":"Timmers HJ, Gimenez-Roqueplo AP, Mannelli M, Pacak K (2009) Clinical aspects of SDHx-related pheochromocytoma and paraganglioma. Endocr Relat Cancer 16:391\u2013400. https:\/\/doi.org\/10.1677\/ERC-08-0284","journal-title":"Endocr Relat Cancer"},{"key":"3138_CR47","doi-asserted-by":"publisher","first-page":"302","DOI":"10.4158\/EP15725.OR","volume":"22","author":"H Turkova","year":"2016","unstructured":"Turkova H, Prodanov T, Maly M et al (2016) Characteristics and outcomes of metastatic SDHB and sporadic pheochromocytoma\/paraganglioma: an national institutes of health study. Endocr Pract 22:302\u2013314. https:\/\/doi.org\/10.4158\/EP15725.OR","journal-title":"Endocr Pract"},{"key":"3138_CR48","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1097\/MED.0b013e32835fcc45","volume":"20","author":"A Vicha","year":"2013","unstructured":"Vicha A, Musil Z, Pacak K (2013) Genetics of pheochromocytoma and paraganglioma syndromes: new advances and future treatment options. Curr Opin Endocrinol Diabetes Obes 20:186\u2013191. https:\/\/doi.org\/10.1097\/MED.0b013e32835fcc45","journal-title":"Curr Opin Endocrinol Diabetes Obes"}],"container-title":["Journal of Cancer Research and Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-020-03138-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00432-020-03138-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-020-03138-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,14]],"date-time":"2021-02-14T09:33:25Z","timestamp":1613295205000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00432-020-03138-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2,15]]},"references-count":48,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,4]]}},"alternative-id":["3138"],"URL":"https:\/\/doi.org\/10.1007\/s00432-020-03138-5","relation":{},"ISSN":["0171-5216","1432-1335"],"issn-type":[{"value":"0171-5216","type":"print"},{"value":"1432-1335","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,2,15]]},"assertion":[{"value":"16 January 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 January 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 February 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed assent from the patients and signed permission from one or both parents were obtained for all the individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}